论文部分内容阅读
自血光量子疗法作为治疗学上的一支新秀,已被广泛用于临床,特别是在治疗脑血管疾病上取得重大进展。为进一步在临床上推广应用,现将我院近两年来用自血光量子疗法治疗急性脑梗死106例报道如下。1 临床资料 206例患者均符合1986年中华医学会第2次全国脑血管病学术会议修订的《各类脑血管疾病诊断要点》的诊断标准,并经CT检查确认,病程<1周的首发病例。随机分成血疗组106例和对照组100例。血疗组:男58例,女48例;年龄40～82岁,平均61岁。对照组:男55例,女45例;年龄41～83岁,平均62岁。血疗组单发性脑梗死52例,多发性脑梗死13
As a rookie of therapeutics, quantum photon therapy has been widely used clinically, especially in the treatment of cerebrovascular disease. To further promote the clinical application, now our hospital in the past two years with self-blood photon therapy of acute cerebral infarction in 106 cases reported as follows. 1 Clinical data 206 patients were in line with the 1986 Chinese Medical Association Second National Conference on cerebrovascular disease revised “diagnostic criteria of various cerebrovascular diseases,” the diagnostic criteria, and confirmed by CT examination, the duration of <1 week of the first case . Randomly divided into blood treatment group 106 cases and control group 100 cases. Blood treatment group: 58 males and 48 females; aged 40 to 82 years, mean 61 years. Control group: 55 males and 45 females; aged 41 to 83 years, mean 62 years. Blood treatment group of 52 cases of single cerebral infarction, multiple cerebral infarction 13